Toleranzia AB
Investor
Toleranzia AB
Description
The company’s internal focus is on preclinical and early clinical research and development, in parallel with business development to find suitable partner for commercialization. Continued clinical development and commercialization will take place in partnership with leading pharmaceutical companies.
Toleranzia AB
Address
Arvid Wallgrens backe 20, 8th floor, SE-413 46 Göteborg
Gothenburg, Sweden
Gothenburg, Sweden
Contact
info@toleranzia.com
Description
The company’s internal focus is on preclinical and early clinical research and development, in parallel with business development to find suitable partner for commercialization. Continued clinical development and commercialization will take place in partnership with leading pharmaceutical companies.
Matchmaking
Connect with Toleranzia AB
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways